L

Lepu Medical Technology Beijing Co Ltd
SZSE:300003

Watchlist Manager
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Watchlist
Price: 11.89 CNY -4.19% Market Closed
Market Cap: 22.4B CNY
Have any thoughts about
Lepu Medical Technology Beijing Co Ltd?
Write Note

Lepu Medical Technology Beijing Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lepu Medical Technology Beijing Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash & Cash Equivalents
ÂĄ3.5B
CAGR 3-Years
0%
CAGR 5-Years
13%
CAGR 10-Years
21%
A
APT Medical Inc
SSE:688617
Cash & Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
120%
CAGR 5-Years
70%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash & Cash Equivalents
ÂĄ6.5B
CAGR 3-Years
35%
CAGR 5-Years
57%
CAGR 10-Years
36%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash & Cash Equivalents
ÂĄ20.5B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash & Cash Equivalents
ÂĄ1.7B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash & Cash Equivalents
ÂĄ7.5B
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Lepu Medical Technology Beijing Co Ltd
Glance View

Market Cap
22.4B CNY
Industry
Health Care

Lepu Medical Technology (Beijing) Co. Ltd. engages in the research, development, production, and sale of medical equipment and accessories. The company is headquartered in Beijing, Beijing and currently employs 10,941 full-time employees. The company went IPO on 2009-10-30. The Company’s main products include stent systems, occluders, bulk drugs, clopidogrel sulfate, atorvastatin calcium tablets, pacemakers, in vitro diagnostic reagents and equipment and surgical instrument, among others. The firm distributes its products in domestic market and to overseas markets.

Intrinsic Value
21.5 CNY
Undervaluation 45%
Intrinsic Value
Price
L

See Also

What is Lepu Medical Technology Beijing Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.5B CNY

Based on the financial report for Sep 30, 2024, Lepu Medical Technology Beijing Co Ltd's Cash & Cash Equivalents amounts to 3.5B CNY.

What is Lepu Medical Technology Beijing Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
21%

Over the last year, the Cash & Cash Equivalents growth was -28%.

Back to Top